On Demand Webinars
Overview and Future Plans of the USP Rapid Microbiological Methods Subcommittee
Presented by Dr David Roesti, PhD. Microbiologist/Facilitator QA/QC at Novartis Pharma AG and Jon Kallay, Senior Technical & Market Development Manager at Charles River Laboratories
29th January 2026
Developing and Deploying Digital & AI Solutions in Pharma: The Reality vs. the Hype
Presented by Saly Romero-Torres, Ph.D. Owner, Hyperplane LLC, Dan Hill, Director, Process Analytics at Fujufilm Biotechnologies, Paul Gillham, Innovations Director, SciY, Ashley Howard, Sr. Director, Product Management A&D at Cytiva and Dr. Alessandro Butté, CEO DataHow
21st January 2026
Strategies for Controlling the Quality of mRNA
Presented by Khaled Yamout, Analytical Sciences, Quality and Manufacturing Consultant, Yamout Chem Consulting, LLC
13th January 2026
An Overview of Recent USP Bacterial Endotoxins Standards Development
Presented by Jay Bolden, Senior Director, Eli Lilly and Company Global Quality Laboratories, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza, Director, Global Technical Services, Veronika Wills, Director, Global Technical Services at Associates of Cape Cod, Inc
12th December 2025
Crossing the Finishing Line: The first Implementation of RTRT/PAT for a BioTech Drug Product at Roche
Presented by Lorenz Liesum, Head of Analytical Science at Roche and Janosch Antczak, Sales Account Manager at Clade
18th November 2025
Challenging Standards for Genetic Characterization of Manufacturing Cell Lines
Presented by Jurgen Mullberg, Expert for Development of Mammalian Cell Lines and Therapeutic Proteins, formerly Associate Director – Cell Substrate & Viral Safety at Bristol Myers Squibb
14th November 2025
Potency Assays and Functional Characterisation – Going Hand-in-Hand during Product Development up to Commercial Licensing
Presented by Therese Choquette, PhD. Head of Analytical and Translational Sciences at Tigen Pharma, Ulrike Herbrand, Scientific Director Global in vitro Bioassays and Head of the Bioassay Research & Development team at Charles River Laboratories and Felix Montero Julian, Vice President of Scientific Affairs at Accellix
13th November 2025
Oncolytic Virus GMP Manufacturing: Solving Antibody Neutralization Challenges with Next Generation Sequencing
Presented by Colette Côté, PhD, U.S. General Manager and Chief Scientific and Portfolio Officer at PathoQuest
12th November 2025
Drive Efficiency With Pre-engineered Solutions for Industrial Automation
Presented by Scott Mangiacotti, Sr. Director, Automation Solutions at Cytiva
06th November 2025
Navigating mRNA Impurities: A Focus on Quality
Presented by Sarita Kattel, M.S, Principal Scientist, Global Biologics at US Pharmacopeia, Melisa Wilson, M.S, Director, Blazar and mRNA QC R&D programs at Merck and Jeremy Schofield, PhD. Senior Scientist, Blazar and mRNA QC R&D program at Merck
04th November 2025
